Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) fell 3.9% during trading on Tuesday . The company traded as low as $0.03 and last traded at $0.71. 5,696 shares changed hands during trading, an increase of 171% from the average session volume of 2,099 shares. The stock had previously closed at $0.74.
Fresh Tracks Therapeutics Price Performance
The firm has a market cap of $4.25 million, a price-to-earnings ratio of -0.50 and a beta of 0.51. The business’s 50-day moving average price is $0.73 and its two-hundred day moving average price is $0.79.
About Fresh Tracks Therapeutics
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
Further Reading
- Five stocks we like better than Fresh Tracks Therapeutics
- The How and Why of Investing in Gold Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Top Biotech Stocks: Exploring Innovation Opportunities
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- About the Markup Calculator
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
